NO20045700L - Orale farmasoytiske preparater som innbefatter ionebytterharpikser med aktiv substanstilsetning og pseudoplastiske geldannende fortykningsmidler - Google Patents

Orale farmasoytiske preparater som innbefatter ionebytterharpikser med aktiv substanstilsetning og pseudoplastiske geldannende fortykningsmidler

Info

Publication number
NO20045700L
NO20045700L NO20045700A NO20045700A NO20045700L NO 20045700 L NO20045700 L NO 20045700L NO 20045700 A NO20045700 A NO 20045700A NO 20045700 A NO20045700 A NO 20045700A NO 20045700 L NO20045700 L NO 20045700L
Authority
NO
Norway
Prior art keywords
pseudoplastic
ion exchange
active substance
pharmaceutical preparations
exchange resins
Prior art date
Application number
NO20045700A
Other languages
English (en)
Other versions
NO333939B1 (no
Inventor
Dirk Mertin
Markus Edingloh
Gert Daube
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of NO20045700L publication Critical patent/NO20045700L/no
Publication of NO333939B1 publication Critical patent/NO333939B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår farmasøytiske preparater for oral administrasjon, nevnte preparater inneholder minst en aktiv ingrediens som er bundet til en ionebytter. Preparatet ifølge oppfinnelsen inneholder også et iboende viskøst geleringsmiddel som et fortykningsmiddel for å forbedre den fysiske stabiliteten og aksepterbarheten, særlig overfor dyr.
NO20045700A 2002-05-31 2004-12-29 Orale farmasøytiske preparater som innbefatter ionebytterharpikser med aktiv substanstilsetning og pseudoplastiske geldannere og anvendelse derav NO333939B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10224086A DE10224086A1 (de) 2002-05-31 2002-05-31 Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
PCT/EP2003/005228 WO2003101422A2 (de) 2002-05-31 2003-05-19 Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker

Publications (2)

Publication Number Publication Date
NO20045700L true NO20045700L (no) 2004-12-29
NO333939B1 NO333939B1 (no) 2013-10-28

Family

ID=29432468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045700A NO333939B1 (no) 2002-05-31 2004-12-29 Orale farmasøytiske preparater som innbefatter ionebytterharpikser med aktiv substanstilsetning og pseudoplastiske geldannere og anvendelse derav

Country Status (28)

Country Link
US (1) US8545829B2 (no)
EP (1) EP1513500B1 (no)
JP (2) JP5350574B2 (no)
KR (3) KR101258373B1 (no)
CN (1) CN1671361B (no)
AR (2) AR039861A1 (no)
AT (1) ATE421317T1 (no)
AU (1) AU2003242545B2 (no)
BR (2) BRPI0311511B1 (no)
CA (1) CA2487648C (no)
CR (1) CR7598A (no)
DE (2) DE10224086A1 (no)
DK (1) DK1513500T3 (no)
ES (1) ES2319115T3 (no)
HK (1) HK1083200A1 (no)
HR (1) HRP20041219B1 (no)
IL (2) IL165322A0 (no)
MX (1) MXPA04011820A (no)
MY (1) MY140953A (no)
NO (1) NO333939B1 (no)
PL (1) PL207269B1 (no)
PT (1) PT1513500E (no)
RU (1) RU2380091C2 (no)
SI (1) SI1513500T1 (no)
TW (1) TWI333422B (no)
UA (1) UA84270C2 (no)
WO (1) WO2003101422A2 (no)
ZA (1) ZA200409616B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
EP1830851A2 (en) * 2004-12-06 2007-09-12 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
DE102005025900A1 (de) * 2005-06-06 2006-12-07 Basf Ag Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
CN100360131C (zh) * 2006-01-24 2008-01-09 新昌国邦化学工业有限公司 一种掩味恩诺沙星的生产方法
US20070248564A1 (en) * 2006-04-25 2007-10-25 Roxane Laboratories, Inc. Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia
CN103349659A (zh) * 2006-09-26 2013-10-16 塔罗制药北美有限公司 液体药物组合物以及应用
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
CA2719246A1 (en) * 2008-03-26 2009-10-01 Taro Pharmaceuticals North America, Inc. Stabilizing lipid compositions for oral pharmaceutical agents
AU2011226523C1 (en) 2010-03-12 2016-07-14 Monsanto Technology Llc Agrochemical gel compositions
EA023294B1 (ru) * 2010-05-19 2016-05-31 Астеллас Фарма Инк. Фармацевтическая композиция, содержащая солифенацин
CN103957894A (zh) 2011-10-19 2014-07-30 R.P.谢勒技术有限公司 两相药物递送系统
FR2998305B1 (fr) * 2012-11-22 2015-02-20 Henkel Ag & Co Kgaa Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire
KR101697095B1 (ko) * 2015-09-30 2017-01-18 주식회사 포스코 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크
CR20200502A (es) 2018-04-25 2020-12-22 Bayer Animal Health Gmbh Proceso para la hidrólisis de ésteres carboxílicos de quinolona
CN114249749B (zh) * 2022-01-08 2024-03-22 天象生物药业邢台有限责任公司 一种马波沙星甲酸盐的转化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60204713A (ja) 1984-03-30 1985-10-16 Zenyaku Kogyo Kk 水性懸濁組成物
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
JP3311350B2 (ja) * 1991-10-28 2002-08-05 ザ、プロクター、エンド、ギャンブル、カンパニー 飲料増粘剤／乳化剤系
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DE59708771D1 (de) * 1996-02-23 2003-01-02 Bayer Ag Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
JP2003504416A (ja) * 1999-07-14 2003-02-04 シェーリング−プラウ・リミテッド イオン交換樹脂を使用する経口キノロン液状製剤の味覚マスキング
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
GB0020089D0 (en) 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
DE10134719A1 (de) * 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
US7001667B2 (en) * 2002-07-17 2006-02-21 Ppg Industries Ohio, Inc. Alkyd-based free radical wood coating compositions

Also Published As

Publication number Publication date
MY140953A (en) 2010-02-12
AU2003242545B2 (en) 2010-02-18
BRPI0311511A8 (pt) 2017-07-11
KR20050010015A (ko) 2005-01-26
RU2004139022A (ru) 2005-07-10
KR20120006092A (ko) 2012-01-17
TWI333422B (en) 2010-11-21
CN1671361A (zh) 2005-09-21
ZA200409616B (en) 2006-05-31
HRP20041219A2 (en) 2006-02-28
WO2003101422A2 (de) 2003-12-11
TW200406230A (en) 2004-05-01
DK1513500T3 (da) 2009-05-11
ATE421317T1 (de) 2009-02-15
HRP20041219B1 (hr) 2013-05-31
CN1671361B (zh) 2010-05-12
BRPI0311511A (no) 2005-02-22
AU2003242545A1 (en) 2003-12-19
RU2380091C2 (ru) 2010-01-27
IL165322A0 (en) 2006-01-15
KR20120123607A (ko) 2012-11-08
EP1513500A2 (de) 2005-03-16
NO333939B1 (no) 2013-10-28
ES2319115T3 (es) 2009-05-04
JP2011012087A (ja) 2011-01-20
DE10224086A1 (de) 2003-12-11
CR7598A (es) 2008-07-31
PT1513500E (pt) 2009-04-02
DE50311123D1 (de) 2009-03-12
PL373456A1 (en) 2005-08-22
CA2487648C (en) 2012-03-13
BR0311511A (pt) 2005-02-22
US20060177414A1 (en) 2006-08-10
AR039861A1 (es) 2005-03-02
CA2487648A1 (en) 2003-12-11
JP5350574B2 (ja) 2013-11-27
MXPA04011820A (es) 2005-03-31
AR105798A2 (es) 2017-11-08
PL207269B1 (pl) 2010-11-30
BRPI0311511B1 (pt) 2018-07-10
EP1513500B1 (de) 2009-01-21
JP2006503806A (ja) 2006-02-02
US8545829B2 (en) 2013-10-01
UA84270C2 (ru) 2008-10-10
KR101258373B1 (ko) 2013-04-30
HK1083200A1 (en) 2006-06-30
WO2003101422A3 (de) 2004-12-09
SI1513500T1 (sl) 2009-06-30
IL165322A (en) 2015-11-30

Similar Documents

Publication Publication Date Title
NO20045700L (no) Orale farmasoytiske preparater som innbefatter ionebytterharpikser med aktiv substanstilsetning og pseudoplastiske geldannende fortykningsmidler
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
DE60024491D1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
SE0402762D0 (sv) Indazole sulphonamide derivatives
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
DK1121127T3 (da) Orale farmaceutiske sammensætninger, som indeholder buprenorphin
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
HRP20090022T3 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
UY27373A1 (es) Formulaciones de interferón beta-humano
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
EA200702386A1 (ru) Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения
MXPA04002099A (es) Composiciones medicinales para neuropatia diabetica.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

MK1K Patent expired